Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
This study is designed to assess the utility and impact of computed tomography (CT)scanning
of the abdomen and pelvis and preoperative serum CA-125 levels in the management of patients
undergoing surgery for presumed ovarian cancer.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To assess the efficacy of preoperative CT scan of the abdomen and pelvis in predicting optimal primary cytoreduction in advanced ovarian cancer.
7 - 35 days postop stage 3 or 4 disease CTscan have
Dennis Chi, M.D.
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|MD Anderson Cancer Center||Houston, Texas 77030-4096|
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|
|Memoral Sloan Kettering Cancer Center||Basking Ridge, New Jersey|
|Memorial Sloan-Kettering Cancer Center @ Suffolk||Commack, New York 11725|
|The Johns Hopkins Hospital||Baltimore, Maryland 21205|